95363 ⎘
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups - in which the condensed system contains two hetero rings Bridged systems
Crystal of pyrrole derivative and method for producing the same
#902Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C
#903Substituted spirocycles
#904Substituted 2-azabicycles and their use as orexin receptor modulators
#905Targeted nitroxide agents
#906Inhibitors of leukotriene A4 hydrolase
#907Biheteroaryl compounds and uses thereof
#908Substituted 2-azabicycles and their use as orexin receptor modulators
#909NRF2 SMALL MOLECULE INHIBITORS FOR CANCER THERAPY
#910CXCR4 Receptor Antagonists
#911P2X7 modulators
#912Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes
#913Muscarinic agonists
#914Heteroaryl compounds useful as inhibitors of E1 activating enzymes
#915GLP-1 receptor modulators
#916ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME
#917Substituted oxetanes and their use as inhibitors of cathepsin C
#918β-lactamase inhibitor and process for preparing the same
#919Process for sodium salt of (2S, 5R)-2-carboxamido-7-oxo-6-sulfooxy -1,6-diaza-bicyclo[3.2.1]octane
#9202,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
#921Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulators
#922Substituted triazolopyridines and methods of use thereof
#923Pyrimidine carboxamides as sodium channel blockers
#924Sodium salt of (2S, 5R)-6-benzyloxy-7-oxo-1,6-diaza-bicyclo [3.2.1] octane-2-carboxylic acid and its preparation
#925Process for preparation of (2S, 5R)-7-oxo-6-sulphooxy-2[((3R)-piperidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo [3.2.1]-octane
#926Process for preparation of (2S, 5R)-7-oxo-6-sulphooxy-2-[((3R)-pyrrolidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo[3.2.1]octance
#927(2S, 5R)-sulfuric acid mono-{[(4-aminopiperidin-4-yl) carbonyl]-7-oxo-1,6-diaza-bicyclo[3.2.1]-oct-6-yl} ester
#928CENTRALLY ACTIVE AND ORALLY BIOAVAILABLE ANTIDOTES FOR ORGANOPHOSPHATE EXPOSURE AND METHODS FOR MAKING AND USING THEM
#929Antiviral compounds
#930Solid forms of an antiviral compound
#931Nitrogen containing heterocyclic compounds
#9321-[m-carboxamido(hetero)aryl-methyl]-heterocyclyl-carboxamide derivatives
#933Nitrogen containing compounds
#934Nitrogen containing compounds and their use
#935Substituted benzimidazole-type piperidine compounds and uses thereof
#936Heterocyclic compounds having cholesterol 24-hydroxylase activity
#937Indole and indoline-type piperidine compounds and uses thereof
#938Azepane derivatives and methods of treating hepatitis B infections
#939Compositions and methods for inhibition of the JAK pathway
#940Fused ring compounds as hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof
#941Inhibitors of the renal outer medullary potassium channel
#942Compositions and methods for 18F-fluorodeoxyglycosylamines
#943Inhibitors of DNA gyrase for the treatment of bacterial infections
#944N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channels
#945Isothiazole derivatives as PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof
#946Pyrimidine derivatives as PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof
#947Pyridine derivatives as PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof
#948Fluorine substituted cyclic amine compounds and preparation methods, pharmaceutical compositions, and uses thereof
#949Tropomyosin-related kinase (TRK) inhibitors
#950Complex and structurally diverse compounds
#951IMIDAZOLE DERIVATIVE
#952Substituted glycinamides, process for their manufacture and use thereof as medicaments
#953Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt
#954Compounds useful for producing an optically active diazabicyclooctane compound
#955ANALOGS AND PRODRUGS OF LOOP DIURETICS, INCLUDING BUMETANIDE, FUROSEMIDE AND PIRETANIDE; COMPOSITIONS AND METHODS OF USE
#956Therapeutics targeting truncated adenomatous polyposis coli (APC) proteins
#957Heterocyclic compounds and uses thereof
#9586-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
#959Phosphatidylinositol 3-kinase inhibitors
#960GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
#961Substituted triazines for malaria treatment and chemoprophylaxis
#962ATX modulating agents
#963Compounds that are S1P modulating agents and/or ATX modulating agents
#964Pyridonemorphinan analogs and biological activity on opioid receptors
#965Compounds that are S1P modulating agents and/or ATX modulating agents
#966Dihydropyridone p1 as factor XIa inhibitors
#967Peripherally acting opioid compounds
#968Substituted imidazo[1,2-a]pyrazines as TNF activity modulators
#969Tropomyosin-related kinase (Trk) inhibitors
#970Propellane-based compounds and the use thereof
#971Bicyclic aza-amides for treatment of psychiatric disorders
#972Substituted morphinans and the use thereof
#973Nitrogen containing compounds
#974Substituted 2-azabicycles and their use as orexin receptor modulators
#975Dihydropyridone P1 as factor XIa inhibitors
#976Nitrogen containing compounds and their use
#977Heterocyclyl pyrimidine analogues as TYK2 inhibitors
#978Histone deacetylase inhibitors
#979Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides
#980Peripheral opioid receptor antagonists and uses thereof
#981Solid forms of an antiviral compound
#982Derivatives of aza adamantane and uses thereof
#983Substituted-quinoxaline-type piperidine compounds and the uses thereof
#984Beta-lactamase inhibitor and process for preparing the same
#985Nitrogen containing compounds and their use
#986Azepane derivatives and methods of treating hepatitis B infections
#987Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
#988Heterocyclic compounds and uses thereof
#989CRYSTALLINE FORM OF A BETA-LACTAMASE INHIBITOR
#990Compounds and methods for treating mammalian gastrointestinal microbial infections
#991Pyrrolopyrimidine compounds as inhibitors of CDK4/6
#992B-lactamase inhibitor picoline salt
#993Compositions and methods for the treatment of respiratory disorders
#9941-aza-bicyclo[3.3.1]nonanes
#995Cyclic amine derivatives as EPreceptor antagonists
#996SUB-TYPE SELECTIVE AMIDES OF DIAZABICYCLOALKANES
#997Sulfamoylating reagents
#998Bridged ring compounds as hepatitis C virus (HCV) inhibitors and pharmaceutical applications thereof
#999Beta-lactamase inhibitor compounds
#1000N-linked lactam M1 receptor positive allosteric mogulators
#1001Cyclic P1 linkers as factor XIa inhibitors
#10028-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
#1003ISOXAZOLE BETA-LACTAMASE INHIBITORS
#1004DIAZABICYCLO[3.3.1]NONANES, METHODS OF SYNTHESIS, AND USES THEREOF
#10051,2,4-OXADIAZOLE AND 1,2,4-THIADIAZOLE BETA-LACTAMASE INHIBITORS
#10061,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE BETA-LACTAMASE INHIBITORS
#10071,2,4-OXADIAZOLE AND 1,2,4-THIADIAZOLE BETA-LACTAMASE INHIBITORS
#1008Nitrogen containing compounds and their use
#1009Nitrogen containing compounds
#1010Diamino heterocyclic carboxamide compound
#1011Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5A receptor modulators
#1012Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-Diazabicyclo[3,2,1]octane-2-carboxamide sodium salt
#10136-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
#1014Morphinan compounds
#1015Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
#1016Biheteroaryl compounds and uses thereof
#1017Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
#1018Beta-lactamase inhibitors
#1019N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase
#10203,6-DIAZABICYCLO[3.1.1]HEPTAINES AS NEURONAL NICOTINIC ACETYCHOLINE RECEPTOR LIGANDS
#1021BETA-LACTAMASE INHIBITORS
#1022Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
#1023Inhibitors of the Renal Outer Medullary Potassium channel
#1024Solid forms of an antiviral compound
#1025Process for preparing a compound useful for producing an optically active diazabicyclooctane compound
#1026MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#1027Heteroaryl compounds useful as inhibitors of E1 activating enzymes
#1028COMPOUNDS AND METHODS OF TREATING HYPERTENSION
#1029Nitrogen containing compounds and their use
#1030Compounds and methods for treatment of hypertension
#10316-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
#1032Nitrogen containing heterocyclic compounds
#1033Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors
#1034Method for producing phenyl-substituted heterocyclic derivative
#1035Substituted 2-azabicycles and their use as orexin receptor modulators
#10365,6,7,8,9,10-hexahydro-6,10-epimino[1,2,4]triazolo[4,3-a]azocines as P2X7 modulators
#1037Substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C
#1038Inhibitors of the Renal Outer Medullary Potassium channel
#1039Nitrogen containing compounds
#1040Compounds useful as inhibitors of ATR kinase
#1041Azole derivative
#1042Crystalline form of a β-lactamase inhibitor
#10431-aza-bicyclo[3.3.1] non-4-yl)-[5-(1H-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenerative disorders
#1044Compounds useful as inhibitors of ATR kinase
#1045Antiviral compounds
#1046Aminopyrimidines as SYK Inhibitors
#1047Biphenyl derivatives
#1048Inhibitors of the renal outer medullary potassium channel
#1049Methods of treating diabetes
#1050Compositions and methods for inhibition of the JAK pathway
#1051Bicyclic compounds and their use as antibacterial agents and betalactamase inhibitors
#10521,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
#1053Antioxidant small molecules aimed at targeting metal-based oxidative stress in neurogenerative disorders
#1054Materials for organic electroluminescence devices
#1055INTRAESOPHAGEAL ADMINISTRATION OF TARGETED NITROXIDE AGENTS FOR PROTECTION AGAINST IONIZING IRRADIATION-INDUCED ESOPHAGITIS
#1056Substituted morphinans and the use thereof
#10577,8-cyclicmorphinan analogs
#1058Oxime-substituted-quinoxaline-type piperidine compounds as ORL-1 modulators
#1059Substituted benzimidazole-type piperidine compounds and uses thereof
#1060Apoptosis promoters
#1061Substituted imidazopyridines as HDM2 inhibitors
#1062Phosphatidylinositol 3-kinase inhibitors
#1063Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
#1064Nitrogen containing morphinan derivatives and the use thereof
#1065Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
#1066Compounds useful as inhibitors of ATR kinase
#1067PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof
#1068PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof
#1069Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof
#10701,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections
#1071Anthelmintic compounds and compositions and method of using thereof
#1072Morphinan compounds
#1073[(1H-INDOL-5-YL) - HETEROARYLOXY] - (1-AZA-BICYCLO [3.3.1] NONANES AS CHOLINERGIC LIGANDS OF THE N-ACHR FOR THE TREATMENT OF PSYCHOTIC AND NEURODEGENRATIVE DISORDERS
#10744-amino-4-oxobutanoyl peptides as inhibitors of viral replication
#1075Chemoselective enrichment for compound isolation
#1076Estrogen receptor modulators and uses thereof
#1077Substituted pyrazines and their use in the treatment of disease
#1078Nitrogen containing compounds and their use
#10791,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections
#1080Heterocyclic compounds with affinity to muscarinic receptors
#1081Peripheral opioid receptor antagonists and uses thereof
#1082Inhibitors of the shiga toxins trafficking through the retrograde pathway
#10831,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
#1084Alicyclic derivatives of N,N'-substituted 3,7-diazabicyclo[3.3.1]nonanes and medicaments based thereon
#1085Cyclic urea- or lactam-substituted quinoxaline-type piperidines as ORL-1 modulators
#1086Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
#1087DIHYDROPYRIDONE P1 AS FACTOR XIA INHIBITORS
#1088Aryl sultam derivatives as RORc modulators
#1089Labelled and un-labelled methyl-pyrrolyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
#1090Bridged heterocyclic compounds and methods of use
#1091Targeted nitroxide agents
#1092Antiviral compounds
#1093Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors
#1094Compositions and methods for inhibition of the JAK pathway
#1095Selective opioid compounds
#1096Isoxazole beta-lactamase inhibitors
#1097Super-oxide dismutase mimetics
#1098Solid forms of an antiviral compound
#1099NEURONAL NICOTINIC AGONIST AND METHODS OF USE
#1100Histone deacetylase inhibitors
#1101Tertiary amines, medicaments containing said amines, use thereof and processes for the preparation thereof
#1102Compositions and methods for inhibition of the JAK pathway
#1103Quinoxalines and AZA-quinoxalines as CRTHreceptor modulators
#11041,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors
#1105Synthesis of [2.2.2]-diazabicyclic ring systems
#1106Beta-lactamase inhibitors
#11071,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors
#11081,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors
#11091,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
#11101,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
#1111Quinazoline compounds as sodium channel blockers
#1112CXCR4 receptor antagonists
#11131,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors
#1114Peripheral opioid receptor antagonists and uses thereof
#1115Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
#1116BETA-LACTAMASE INHIBITORS
#11171,3-Oxathiolane derivatives, process for the preparation of 1,3-Oxathiolane derivatives and intermediates thereof
#1118(1R,4R) 7-OXO-2-AZABICYCLO[2.2.2]OCT-5-ENE AND DERIVATIVES THEREOF
#1119Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt
#1120Heteroaryloxyheterocyclyl compounds as PDE10 inhibitors
#1121Inhibitors of the renal outer medullary potassium channel
#1122Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
#1123Inhibitors of the renal outer medullary potassium channel
#1124(+)-3-HYDROXYMORPHINAN-BASED POLYCYCLE DERIVATIVES
#1125Cycloalkyl substituted pyrimidinediamine compounds and their uses
#1126Bicyclic amides for enhancing glutamatergic synaptic responses
#1127Pyrido[3,4-B]indoles and methods of use
#1128Bridged heterocyclic compounds and methods of use
#1129Pyrido [4,3-b] indole and pyrido [3,4-b] indole derivatives and methods of use
#1130Benzyl sulfonamide derivatives as RORc modulators
#1131Quinazoline derivatives substituted by aniline, preparation method and use thereof
#1132Bridged heterocyclic compounds and methods of use
#1133Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators
#1134Cannabinoid receptor modulators
#1135Bridged heterocyclic compounds and methods of use
#1136Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C
#1137Pyrrolopyrimidine compounds as inhibitors of CDK4/6
#1138Cephem compound having catechol group
#1139HIGHLY PURE VARENICLINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF SUBSTANTIALLY FREE OF METHYLVARENICLINE IMPURITY
#1140Azaadamantane derivatives and methods of use
#11416-(4-hydroxy-phenyl)-3-alkyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
#1142Pyrazole compounds
#1143PROCESS FOR PREPARING VARENICLINE, VARENICLINE INTERMEDIATES, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
#11444-aryl-2-anilino-pyrimidines
#1145Imidazo[1,2-a]pyridine derivative
#11464-fluoro-4-arylpiperdin-1-yl derivatives as mu opioid function moderators
#1147Amino heteroaryl compounds as beta-secretase modulators and methods of use
#1148Amide derivative and use thereof as medicine
#1149Method for producing 3,7-diaza-bicyclo[3.3.1]nonane-metal complex solutions
#1150PROCESS FOR THE PREPARATION OF VARENICLINE
#1151Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
#1152Substituted pyridinyl-pyrimidines and their use as medicaments
#1153Peripheral opioid receptor antagonists and uses thereof
#1154Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes
#1155Peripherally acting opioid compounds
#1156Diazabicyclononyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators
#1157Cocaine analogs and methods of preparation and uses thereof
#1158Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
#1159Methods of producing sulfate salts of cations from heteroatomic compounds and dialkyl sulfates and uses thereof
#1160Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors
#1161SYNTHESIS OF HETERO COMPOUNDS USING DIALKYLCARBONATE QUATERNATION
#1162Ionic liquid containing sulfonate ions
#1163Reductive amination of 6-keto morphinans by catalytic hydrogen transfer
#1164Peripheral opioid receptor antagonists and uses thereof
#1165Macrocycles as factor XIa inhibitors
#11663,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetycholine receptor ligands
#1167Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
#1168Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes
#1169Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action
#1170PROCESS FOR THE PREPARATION OF SUBSTITUTED QUINOXALINES
#1171Derivatives of N-[(1-pyrazol-1-yl)aryl]-1-indole or 1-indazole-3-carboxamide, preparation thereof and applications thereof in therapeutics
#1172Aminopyrimidines as SYK inhibitors
#1173Methods and compositions of treating a flaviviridae family viral infection
#1174Bifunctional polyazamacrocyclic chelating agents
#1175Adamantane analogs
#1176Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors
#1177Antiviral compounds
#1178Monohydrate of azaadamantane derivatives
#1179NON-POLAR AND POLAR LEAVING GROUPS
#1180NOVEL BENZODIOXOLYL-OXADIAZOLYL-DIAZABICYCLONONANE DERIVATIVES AND THEIR MEDICAL USE
#1181Derivatives of (bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors
#1182Antimicrobial compounds and methods of making and using the same
#1183Modulators of cystic fibrosis transmembrane conductance regulator
#1184Heterocyclic derivatives
#1185Azabicycloalkane derivatives, preparation thereof and use thereof in therapy
#1186Fused heterocyclic compounds as orexin receptor modulators
#1187Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
#11881,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use
#1189Optically active diazabicyclooctane derivatives and process for preparing the same
#1190Antiviral compounds
#1191Ether benzotriazole derivatives
#11923-substituted-2-(arlyalkyl)-1-azabicycloalkanes and methods of use thereof
#1193Small molecule CD4 mimetics and uses thereof
#11942,3,4,5-tetrahydro-benzo{B}{1,4}diazepine-comprising compounds of formula(III) for treating pain
#1195Compounds and methods for treating mammalian gastrointestinal microbial infections
#1196FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF
#1197Heterocyclic compounds with affinity to muscarinic receptors
#1198Tricyclic δ-opioid modulators
#1199Chemical Compounds 637
#1200Heteroaryl compounds useful as inhibitors of E1 activating enzymes